Regulus Therapeutics Inc. (RGLS) stock prices updated...
 

Regulus Therapeutics Inc. stock price

Regulus Therapeutics Inc. latest news:


  • 12/19/2017 06:35:13

    BRIEF-Regulus Announces First-in-Human Dosing For Phase I Study Of RGLS4326

    Regulus Therapeutics Inc(RGLS): * REGULUS ANNOUNCES FIRST-IN-HUMAN DOSING FOR PHASE I STUDY OF RGLS4326 FOR THE TREATMENT OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE Source text for Eikon: Further company coverage:

  • More trends:

    Reis, IncREIS | Reliv'' International, Inc.RELV | Relypsa, Inc.RLYP | Remark Media, Inc.MARK | Remy International, Inc.REMY | Renasant CorporationRNST | Renewable Energy Group, Inc.REGI | Rent-A-Center Inc.RCII | Rentech, Inc.RTK | Rentrak CorporationRENT |